Photo: Tara Winstead/Pexels
Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate cancer, the most commonly diagnosed cancer in over 100 countries and the second leading cause of cancer-related deaths among men in the US. A collaborative study, spearheaded by Michael King, a professor of bioengineering at Rice, and Charles Caskey, an associate professor at Vanderbilt, highlights a non-invasive method that enables targeted treatment directly at tumor sites while limiting damaging effects on surrounding healthy tissues. The combined application of FUS and TRAIL substantially diminished the number of cancer cells and the overall size of tumors compared to administering either treatment alone. “This foundational study lays the groundwork for a potential new therapy for prostate cancer,” said King.
|
|
More:
